Genetic and clinical features of familial Mediterranean fever in a cohort of patients with kidney failure
- PMID: 40347209
- DOI: 10.1007/s40620-025-02272-y
Genetic and clinical features of familial Mediterranean fever in a cohort of patients with kidney failure
Abstract
Background: Familial Mediterranean fever (FMF) often manifests as recurrent inflammatory episodes, potentially leading to secondary amyloidosis. Many studies have assessed the clinical correlation between FMF and Mediterranean fever (MEFV) gene variants (FMF type I). However, few studies have focused on patients who remain relatively asymptomatic and present with renal amyloidosis (FMF type II). We hypothesize that patients with kidney failure carry higher rates of FMF variants. Therefore, our study aimed to assess the rates and types of FMF gene variants in a cohort of patients with kidney failure compared to healthy controls of the same area.
Methods: This is a cross-sectional study involving a hemodialysis cohort compared to healthy controls. The controls were healthy university students recruited from the Hashemite University campus. Both groups underwent genetic screening for FMF using polymerase chain reaction and reverse hybridization. Patients with positive genetic screening were offered a colonoscopy with rectal biopsies, which were assessed for the deposition of amyloid proteins.
Results: Genetic analysis of the cohort of patients with kidney failure revealed remarkable differences in allele frequency rates across different genotypes. The positivity rate in the hemodialysis cohort reached 16.0%, compared to 12.9% in the healthy controls (p = 0.342, X2 = 0.902). Among the different genotypes, V726A and M694V were significantly different between the two groups, with p-values of 0.009 and 0.035, respectively.
Conclusion: In our population, patients with kidney failure carried a higher allele frequency of some FMF variants than healthy controls. The M694V and V726A mutations were associated with kidney failure.
Keywords: End-stage kidney disease; Familial Mediterranean fever; Genetic mutations; Polymerase chain reaction; Rectal amyloidosis.
© 2025. The Author(s) under exclusive licence to Italian Society of Nephrology.
Conflict of interest statement
Declarations. Conflict of interest: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. Ethical approval: This study was approved by the Institutional Review Boards at PHH (approval number: MH/Research/11424) and HU (approval number: No.9/8/2021/2022). Human and animal rights: This study complies with guidelines of human studies. This study does not contain any study of animals. Informed consent: Informed consent was obtained from all individual participants included in the study.
Similar articles
-
The M694I/M694I genotype: A genetic risk factor of AA-amyloidosis in a group of Algerian patients with familial Mediterranean fever.Eur J Med Genet. 2017 Mar;60(3):149-153. doi: 10.1016/j.ejmg.2016.12.003. Epub 2016 Dec 10. Eur J Med Genet. 2017. PMID: 27956278
-
Genotype-phenotype correlation in patients with familial Mediterranean fever in East Anatolia (Turkey).Genet Test Mol Biomarkers. 2010 Jun;14(3):325-8. doi: 10.1089/gtmb.2009.0189. Genet Test Mol Biomarkers. 2010. PMID: 20373849
-
Association of FMF-related (MEFV) point mutations with secondary and FMF amyloidosis.Nephron Clin Pract. 2004;96(4):c131-5. doi: 10.1159/000077375. Nephron Clin Pract. 2004. PMID: 15122067
-
[Familial Mediterranean Fever (FMF): from diagnosis to treatment].Sante. 2004 Oct-Dec;14(4):261-6. Sante. 2004. PMID: 15745878 Review. French.
-
Phenotype 2 familial mediterranean fever: evaluation of 22 case series and review of the literature on phenotype 2 FMF.Ren Fail. 2013;35(2):226-30. doi: 10.3109/0886022X.2012.745115. Epub 2012 Dec 11. Ren Fail. 2013. PMID: 23228227 Review.
References
-
- Di Ciaula A, Iacoviello M, Bonfrate L et al (2023) Genetic and clinical features of familial Mediterranean fever (FMF) in a homogeneous cohort of patients from South-Eastern Italy. Eur J Intern Med 115:79–87. https://doi.org/10.1016/J.EJIM.2023.05.015 - DOI - PubMed
-
- Ben-Chetrit E, Touitou I (2024) The significance of carrying MEFV variants in symptomatic and asymptomatic individuals. Clin Genet 106(3):217–223. https://doi.org/10.1111/CGE.14566 - DOI - PubMed
-
- Kuru FT, Gokcen N, Yazici A, Cefle A (2023) Disease severity and genotype–phenotype correlation in adult patients with familial Mediterranean fever. Mod Rheumatol 34(1):214–219. https://doi.org/10.1093/MR/ROAD007 - DOI
-
- Dewalle M, Domingo C, Rozenbaum M et al (1998) Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 6(1):95–97. https://doi.org/10.1038/SJ.EJHG.5200170 - DOI - PubMed
-
- Ece A, Çakmak E, Uluca Ü et al (2014) The MEFV mutations and their clinical correlations in children with familial Mediterranean fever in southeast Turkey. Rheumatol Int 34(2):207–212. https://doi.org/10.1007/S00296-013-2858-1/METRICS - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical